{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:13:27Z","timestamp":1788362007972,"version":"build-2803163510"},"reference-count":152,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Secretar\u00eda de Ciencia, Humanidades, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["Ciencia de Frontera 2019-6380"],"award-info":[{"award-number":["Ciencia de Frontera 2019-6380"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Secretar\u00eda de Ciencia, Humanidades, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CBF2023-2024-655"],"award-info":[{"award-number":["CBF2023-2024-655"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.micpath.2026.108771","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:16:55Z","timestamp":1786547815000},"page":"108771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Antifungals: mechanism of action, resistance, and therapeutic perspectives"],"prefix":"10.1016","volume":"219","author":[{"given":"Manuela","family":"G\u00f3mez-Gaviria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6973-0595","authenticated-orcid":false,"given":"H\u00e9ctor M.","family":"Mora-Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.micpath.2026.108771_bib1","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab593","article-title":"Prevalence and healthcare burden of fungal infections in the United States, 2018","volume":"9","author":"Rayens","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108771_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108731","article-title":"Invasive fungal disease and the immunocompromised host including allogeneic hematopoietic cell transplant recipients: improved understanding and new strategic approach with sargramostim","volume":"228","author":"Chu","year":"2021","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.micpath.2026.108771_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/life15020145","article-title":"Recognizing the importance of public health mycology","volume":"15","author":"Bongomin","year":"2025","journal-title":"Life"},{"issue":"1","key":"10.1016\/j.micpath.2026.108771_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/jof12010059","article-title":"Early antifungal treatment in immunocompromised patients, including hematological and critically ill patients","volume":"12","author":"Klyasova","year":"2026","journal-title":"J Fungi (Basel)"},{"issue":"Supplement_3","key":"10.1016\/j.micpath.2026.108771_bib5","doi-asserted-by":"crossref","first-page":"S307","DOI":"10.1093\/mmy\/myy136","article-title":"Invasive fungal infections in the immunocompromised host: mechanistic insights in an era of changing immunotherapeutics","volume":"57","author":"Eades","year":"2019","journal-title":"Med. Mycol."},{"issue":"9","key":"10.1016\/j.micpath.2026.108771_bib6","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3390\/jof11090617","article-title":"Pulmonary aspergillosis in immunocompromised critically ill patients: prevalence, risk factors, clinical features and diagnosis-a narrative review","volume":"11","author":"Bocci","year":"2025","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.micpath.2026.108771_bib7","doi-asserted-by":"crossref","DOI":"10.1590\/0074-02760200430","article-title":"Invasive fungal disease in humans: are we aware of the real impact?","volume":"115","author":"Firacative","year":"2020","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.micpath.2026.108771_bib8","first-page":"15","article-title":"New antifungal strategies and drug development against WHO critical priority fungal pathogens","author":"Li","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"7","key":"10.1016\/j.micpath.2026.108771_bib9","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41579-021-00511-0","article-title":"Treatment strategies for cryptococcal infection: challenges, advances and future outlook","volume":"19","author":"Iyer","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"issue":"6390","key":"10.1016\/j.micpath.2026.108771_bib10","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.aap7999","article-title":"Worldwide emergence of resistance to antifungal drugs challenges human health and food security","volume":"360","author":"Fisher","year":"2018","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.micpath.2026.108771_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/idr17040091","article-title":"Antifungal agents in the 21st century: advances, challenges, and future perspectives","volume":"17","author":"Branda","year":"2025","journal-title":"Infect. Dis. Rep."},{"issue":"19","key":"10.1016\/j.micpath.2026.108771_bib12","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1016\/j.cell.2024.08.016","article-title":"Focus on fungi","volume":"187","author":"Iliev","year":"2024","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.micpath.2026.108771_bib13","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3390\/biomedicines11041063","article-title":"Antifungal drug resistance: an emergent health threat","volume":"11","author":"Vitiello","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.micpath.2026.108771_bib14","first-page":"557","article-title":"Tackling the emerging threat of antifungal resistance to human health","author":"Fisher","year":"2022"},{"issue":"3","key":"10.1016\/j.micpath.2026.108771_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3892\/mmr.2025.13612","article-title":"Antifungal resistance: emerging mechanisms and implications","volume":"32","author":"Kadariswantiningsih","year":"2025","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.micpath.2026.108771_bib16","doi-asserted-by":"crossref","DOI":"10.3897\/imafungus.17.171995","article-title":"Interconnected worlds: a comprehensive review of fungal defenses, antimicrobial resistance, and their evolutionary dynamics","volume":"17","author":"Sui","year":"2026","journal-title":"IMA Fungus"},{"issue":"6","key":"10.1016\/j.micpath.2026.108771_bib17","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s11046-023-00759-5","article-title":"The role of novel antifungals in the management of candidiasis: a clinical perspective","volume":"188","author":"Ordaya","year":"2023","journal-title":"Mycopathologia"},{"issue":"8","key":"10.1016\/j.micpath.2026.108771_bib18","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1016\/j.apsb.2025.06.013","article-title":"Next-generation antifungal drugs: mechanisms, efficacy, and clinical prospects","volume":"15","author":"Lu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.micpath.2026.108771_bib19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/jof6040321","article-title":"Amphotericin B and other polyenes-discovery, clinical use, mode of action and drug resistance","volume":"6","author":"Carolus","year":"2020","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"10.1016\/j.micpath.2026.108771_bib20","first-page":"1","article-title":"Antifungal macrocycle antibiotic amphotericin B-its present and future. multidisciplinary perspective for the use in the medical practice","volume":"16","author":"Baghirova","year":"2022","journal-title":"Biochem Mosc Suppl B Biomed Chem"},{"issue":"8","key":"10.1016\/j.micpath.2026.108771_bib21","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3390\/pharmaceutics16081065","article-title":"Polyene-based derivatives with antifungal activities","volume":"16","author":"Ngece","year":"2024","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.micpath.2026.108771_bib22","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1073\/pnas.1117280109","article-title":"Amphotericin primarily kills yeast by simply binding ergosterol","volume":"109","author":"Gray","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.micpath.2026.108771_bib23","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3390\/antibiotics9080445","article-title":"Current antimycotics, new prospects, and future approaches to antifungal therapy","volume":"9","author":"Wall","year":"2020","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"10.1016\/j.micpath.2026.108771_bib24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s44259-023-00007-2","article-title":"Molecular mechanisms governing antifungal drug resistance","volume":"1","author":"Lee","year":"2023","journal-title":"NPJ Antimicrob Resist"},{"issue":"4","key":"10.1016\/j.micpath.2026.108771_bib25","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.micpath.2026.108771_bib26","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect. Dis."},{"issue":"37","key":"10.1016\/j.micpath.2026.108771_bib27","doi-asserted-by":"crossref","first-page":"9173","DOI":"10.1039\/D4TB01484G","article-title":"Nanomaterial-based therapeutics for enhanced antifungal therapy","volume":"12","author":"Liu","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.micpath.2026.108771_bib28","article-title":"Nanotechnology-driven antifungal strategies: a systematic review of mechanisms, therapeutic efficacy, and translational barriers in combating drug-resistant fungal infections","volume":"8","author":"Oso","year":"2025","journal-title":"Nanotechnology"},{"key":"10.1016\/j.micpath.2026.108771_bib29","article-title":"The evolution of antifungal therapy: traditional agents, current challenges and future perspectives","volume":"8","author":"Souza","year":"2025","journal-title":"Curr. Res. Microb. Sci."},{"issue":"5","key":"10.1016\/j.micpath.2026.108771_bib30","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3390\/antibiotics12050884","article-title":"Antifungals: from pharmacokinetics to clinical practice","volume":"12","author":"Carmo","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.micpath.2026.108771_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2025.107776","article-title":"Advances in transdermal delivery systems for antifungals: current approaches and future perspectives","volume":"206","author":"Hamed","year":"2025","journal-title":"Microb. Pathog."},{"issue":"12","key":"10.1016\/j.micpath.2026.108771_bib32","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1002\/jhet.4348","article-title":"Recent progress in the synthesis of azoles and related five-membered ring heterocycles using silica-supported heterogeneous catalysts","volume":"58","author":"Chanu","year":"2021","journal-title":"J. Heterocycl. Chem."},{"issue":"3","key":"10.1016\/j.micpath.2026.108771_bib33","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/metabo10030106","article-title":"Antifungal drugs","volume":"10","author":"Hou\u0161\u0165","year":"2020","journal-title":"Metabolites"},{"issue":"8","key":"10.1016\/j.micpath.2026.108771_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011583","article-title":"Azole potentiation in Candida species","volume":"19","author":"Stenkiewicz-Witeska","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2026.108771_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.fgb.2019.103254","article-title":"Facilitators of adaptation and antifungal resistance mechanisms in clinically relevant fungi","volume":"132","author":"Hokken","year":"2019","journal-title":"Fungal Genet. Biol."},{"issue":"3","key":"10.1016\/j.micpath.2026.108771_bib152","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3390\/microorganisms14030599","article-title":"The silent pandemic: antifungal resistance and the future of invasive fungal disease management","volume":"14","author":"Bagga","year":"2026","journal-title":"Microorganisms"},{"issue":"5","key":"10.1016\/j.micpath.2026.108771_bib36","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.3390\/ijms23052756","article-title":"Emerging antifungal targets and strategies","volume":"23","author":"Ivanov","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.micpath.2026.108771_bib37","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1080\/14756366.2022.2050224","article-title":"Echinocandins - structure, mechanism of action and use in antifungal therapy","volume":"37","author":"Szyma\u0144ski","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"9390","key":"10.1016\/j.micpath.2026.108771_bib38","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(03)14472-8","article-title":"Echinocandin antifungal drugs","volume":"362","author":"Denning","year":"2003","journal-title":"Lancet"},{"issue":"Suppl 6","key":"10.1016\/j.micpath.2026.108771_bib39","doi-asserted-by":"crossref","first-page":"S604","DOI":"10.1093\/cid\/civ814","article-title":"Echinocandins: the expanding antifungal armamentarium","volume":"61","author":"Aguilar-Zapata","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.micpath.2026.108771_bib40","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.micpath.2026.108771_bib41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.fgb.2009.09.003","article-title":"Fungal echinocandin resistance","volume":"47","author":"Walker","year":"2010","journal-title":"Fungal Genet. Biol."},{"issue":"Suppl 6","key":"10.1016\/j.micpath.2026.108771_bib42","doi-asserted-by":"crossref","first-page":"S612","DOI":"10.1093\/cid\/civ791","article-title":"Echinocandin resistance in Candida","volume":"61","author":"Perlin","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108771_bib43","article-title":"Flucytosine and its clinical usage","volume":"10","author":"Sigera","year":"2023","journal-title":"Ther. Adv. Infect. Dis."},{"issue":"3","key":"10.1016\/j.micpath.2026.108771_bib44","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1128\/AAC.01188-06","article-title":"Oral versus intravenous flucytosine in patients with human immunodeficiency virus-associated cryptococcal meningitis","volume":"51","author":"Brouwer","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.micpath.2026.108771_bib45","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3390\/jof9050565","article-title":"Fungal drug response and antimicrobial resistance","volume":"9","author":"Osset-Tr\u00e9nor","year":"2023","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"10.1016\/j.micpath.2026.108771_bib46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/ijp.ijp_1129_25","article-title":"A quiet but growing threat: global perspectives on antifungal resistance and future therapeutic approaches","volume":"58","author":"Gurajala","year":"2026","journal-title":"Indian J. Pharmacol."},{"issue":"165","key":"10.1016\/j.micpath.2026.108771_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.micpath.2026.108771_bib48","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1146\/annurev-micro-051024-033116","article-title":"Pathogenic fungal sensing and responses to stressful host environments","volume":"79","author":"Rapala","year":"2025","journal-title":"Annu. Rev. Microbiol."},{"issue":"7","key":"10.1016\/j.micpath.2026.108771_bib49","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a019752","article-title":"Mechanisms of antifungal drug resistance","volume":"5","author":"Cowen","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.micpath.2026.108771_bib50","first-page":"8","article-title":"Cellular and molecular defects underlying invasive fungal infections\u2014revelations from endemic mycoses","author":"Lee","year":"2017","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.micpath.2026.108771_bib51","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/1567-1364.12042","article-title":"Erg11 mutations associated with azole resistance in clinical isolates of Candida albicans","volume":"13","author":"Xiang","year":"2013","journal-title":"FEMS Yeast Res."},{"issue":"5","key":"10.1016\/j.micpath.2026.108771_bib52","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ijantimicag.2017.05.012","article-title":"Molecular basis of antifungal drug resistance in yeasts","volume":"50","author":"Morio","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"12","key":"10.1016\/j.micpath.2026.108771_bib53","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3390\/jof10120820","article-title":"The molecular basis of the intrinsic and acquired resistance to azole antifungals in Aspergillus fumigatus","volume":"10","author":"Hosseini","year":"2024","journal-title":"J Fungi (Basel)"},{"issue":"3","key":"10.1016\/j.micpath.2026.108771_bib54","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.steroids.2007.11.005","article-title":"Ergosterol biosynthesis pathway in Aspergillus fumigatus","volume":"73","author":"Alcazar-Fuoli","year":"2008","journal-title":"Steroids"},{"key":"10.1016\/j.micpath.2026.108771_bib55","first-page":"439","article-title":"Ergosterol biosynthesis in Aspergillus fumigatus: its relevance as an antifungal target and role in antifungal drug resistance","volume":"3","author":"Alcazar-Fuoli","year":"2012","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.micpath.2026.108771_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01839-20","article-title":"The C(2)H(2) transcription factor SltA contributes to azole resistance by coregulating the expression of the drug target Erg11A and the drug efflux pump Mdr1 in Aspergillus fumigatus","volume":"65","author":"Du","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.micpath.2026.108771_bib57","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01919-15","article-title":"The Aspergillus fumigatus damage resistance protein family coordinately regulates ergosterol biosynthesis and azole susceptibility","volume":"7","author":"Song","year":"2016","journal-title":"mBio"},{"issue":"11","key":"10.1016\/j.micpath.2026.108771_bib58","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.3390\/microorganisms11112757","article-title":"The microevolution of antifungal drug resistance in pathogenic fungi","volume":"11","author":"Boyce","year":"2023","journal-title":"Microorganisms"},{"issue":"3","key":"10.1016\/j.micpath.2026.108771_bib59","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1128\/AAC.05502-11","article-title":"Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14\u03b1-demethylase (Erg11) residue critical for differential susceptibility between fluconazole\/voriconazole and itraconazole\/posaconazole","volume":"56","author":"Sionov","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.micpath.2026.108771_bib60","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/pathogens13020128","article-title":"Antifungal resistance in cryptococcal infections","volume":"13","author":"Melhem","year":"2024","journal-title":"Pathogens"},{"issue":"4","key":"10.1016\/j.micpath.2026.108771_bib61","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7705\/biomedica.6519","article-title":"Perfiles de expresi\u00f3n de los genes ERG11, MDR1 y AFR1 en Cryptococcus neoformans var. grubii aislados de pacientes con VIH","volume":"42","author":"Torres","year":"2022","journal-title":"Biomedica"},{"key":"10.1016\/j.micpath.2026.108771_bib62","first-page":"13","article-title":"Molecular epidemiology and antifungal resistance of Cryptococcus neoformans from human immunodeficiency virus-negative and human immunodeficiency virus-positive patients in eastern China","author":"Zhou","year":"2022","journal-title":"Front. Microbiol."},{"issue":"12","key":"10.1016\/j.micpath.2026.108771_bib63","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3390\/jof11120875","article-title":"Drug discovery and repurposing for Coccidioides: a systematic review","volume":"11","author":"Saeger","year":"2025","journal-title":"J. Fungi"},{"key":"10.1016\/j.micpath.2026.108771_bib64","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/1471-2164-15-254","article-title":"Transcriptional profile of Paracoccidioides spp. in response to itraconazole","volume":"15","author":"da Silva Neto","year":"2014","journal-title":"BMC Genom."},{"issue":"11","key":"10.1016\/j.micpath.2026.108771_bib65","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3390\/jof7110981","article-title":"Deletion of the stress response gene DDR48 from Histoplasma capsulatum increases sensitivity to oxidative stress, increases susceptibility to antifungals, and decreases fitness in macrophages","volume":"7","author":"Blancett","year":"2021","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"10.1016\/j.micpath.2026.108771_bib66","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s42770-020-00307-z","article-title":"Antifungal resistance on Sporothrix species: an overview","volume":"52","author":"Waller","year":"2021","journal-title":"Braz. J. Microbiol."},{"issue":"4","key":"10.1016\/j.micpath.2026.108771_bib67","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01620-23","article-title":"Bimodal distribution of azole susceptibility in Sporothrix brasiliensis isolates in Brazil","volume":"68","author":"Ribeiro Dos Santos","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.micpath.2026.108771_bib68","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.3390\/microorganisms10112152","article-title":"Sporotrichosis: a review of a neglected disease in the last 50 years in Brazil","volume":"10","author":"Alvarez","year":"2022","journal-title":"Microorganisms"},{"issue":"4","key":"10.1016\/j.micpath.2026.108771_bib69","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3390\/microorganisms13040862","article-title":"Regulation of ergosterol biosynthesis in pathogenic fungi: opportunities for therapeutic development","volume":"13","author":"Song","year":"2025","journal-title":"Microorganisms"},{"issue":"8","key":"10.1016\/j.micpath.2026.108771_bib70","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1128\/AAC.49.8.3264-3273.2005","article-title":"Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates","volume":"49","author":"Park","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.micpath.2026.108771_bib71","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/2047-783X-16-4-153","article-title":"Epidemiology and antifungal resistance in invasive aspergillosis according to primary disease: review of the literature","volume":"16","author":"Mayr","year":"2011","journal-title":"Eur. J. Med. Res."},{"issue":"4","key":"10.1016\/j.micpath.2026.108771_bib72","doi-asserted-by":"crossref","DOI":"10.1111\/myc.70051","article-title":"Antifungal resistance in Non-fumigatus Aspergillus Species","volume":"68","author":"Djenontin","year":"2025","journal-title":"Mycoses"},{"issue":"7","key":"10.1016\/j.micpath.2026.108771_bib73","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1128\/AAC.49.7.2851-2856.2005","article-title":"Cryptococcus neoformans resistance to echinocandins: (1,3)beta-glucan synthase activity is sensitive to echinocandins","volume":"49","author":"Maligie","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.micpath.2026.108771_bib74","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01952-19","article-title":"A mechanosensitive channel governs lipid flippase-mediated echinocandin resistance in Cryptococcus neoformans","volume":"10","author":"Cao","year":"2019","journal-title":"mBio"},{"issue":"3","key":"10.1016\/j.micpath.2026.108771_bib75","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3390\/antibiotics12030608","article-title":"Potential strategies to control the risk of antifungal resistance in humans: a comprehensive review","volume":"12","author":"Rabaan","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.micpath.2026.108771_bib76","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9870679","article-title":"Antifungal resistance, metabolic routes as drug targets, and new antifungal agents: an overview about endemic dimorphic fungi","volume":"2017","author":"Parente-Rocha","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.micpath.2026.108771_bib77","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6722245","article-title":"Molecular mechanisms of antifungal resistance in mucormycosis","volume":"2022","author":"Ganesan","year":"2022","journal-title":"Biomed Res. Int."},{"issue":"3","key":"10.1016\/j.micpath.2026.108771_bib78","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/genes11030317","article-title":"Genes, pathways, and mechanisms involved in the virulence of mucorales","volume":"11","author":"Lax","year":"2020","journal-title":"Genes"},{"issue":"3","key":"10.1016\/j.micpath.2026.108771_bib79","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3390\/jof9030335","article-title":"Mucorales and mucormycosis: recent insights and future prospects","volume":"9","author":"Tahiri","year":"2023","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"10.1016\/j.micpath.2026.108771_bib80","doi-asserted-by":"crossref","DOI":"10.1128\/mmbr.00188-22","article-title":"Molecular mechanisms that govern infection and antifungal resistance in Mucorales","volume":"88","author":"Lax","year":"2024","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"2","key":"10.1016\/j.micpath.2026.108771_bib81","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00686-22","article-title":"Serine\/threonine phosphatase calcineurin orchestrates the intrinsic resistance to micafungin in the human-pathogenic fungus Mucor circinelloides","volume":"67","author":"Garcia","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.micpath.2026.108771_bib82","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02949-19","article-title":"A novel resistance pathway for calcineurin inhibitors in the human-pathogenic Mucorales Mucor circinelloides","volume":"11","author":"Vellanki","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.micpath.2026.108771_bib83","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.20360","article-title":"Efflux systems driving resistance and virulence across biological domains","volume":"13","author":"Almeida da Silva","year":"2025","journal-title":"PeerJ"},{"key":"10.1016\/j.micpath.2026.108771_bib84","first-page":"5","article-title":"MFS multidrug transporters in pathogenic fungi: do they have real clinical impact?","author":"Costa","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.micpath.2026.108771_bib85","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fphar.2014.00202","article-title":"Efflux pump proteins in antifungal resistance","volume":"5","author":"Prasad","year":"2014","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.micpath.2026.108771_bib86","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/CMR.00051-08","article-title":"Efflux-mediated antifungal drug resistance","volume":"22","author":"Cannon","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"issue":"10","key":"10.1016\/j.micpath.2026.108771_bib87","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3390\/jof11100731","article-title":"Azole-resistant Aspergillus fumigatus: epidemiology, diagnosis, and treatment considerations","volume":"11","author":"Zubovskaia","year":"2025","journal-title":"J. Fungi"},{"issue":"11","key":"10.1016\/j.micpath.2026.108771_bib88","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3390\/pathogens12111305","article-title":"Drug-resistant Aspergillus spp.: a literature review of its resistance mechanisms and its prevalence in Europe","volume":"12","author":"De Francesco","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.micpath.2026.108771_bib89","first-page":"14","article-title":"Comparative analysis of the biological characteristics and mechanisms of azole resistance of clinical Aspergillus fumigatus strains","author":"Zeng","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108771_bib90","article-title":"Fungal infections: pathogenesis, antifungals and alternate treatment approaches","volume":"3","author":"Reddy","year":"2022","journal-title":"Curr. Res. Microb. Sci."},{"key":"10.1016\/j.micpath.2026.108771_bib91","first-page":"9","article-title":"Dermatophyte resistance to antifungal drugs: mechanisms and prospectus","author":"Martinez-Rossi","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108771_bib92","first-page":"11","article-title":"Characterization of three pleiotropic drug resistance transporter genes and their participation in the azole resistance of Mucor circinelloides","author":"Nagy","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"11","key":"10.1016\/j.micpath.2026.108771_bib93","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/jac\/dkaf343","article-title":"Multidrug efflux pumps and innate azole resistance of Mucor lusitanicus","volume":"80","author":"Toepfer","year":"2025","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.micpath.2026.108771_bib94","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/jof3010008","article-title":"Candida species biofilms' antifungal resistance","volume":"3","author":"Silva","year":"2017","journal-title":"J Fungi (Basel)"},{"issue":"3","key":"10.1016\/j.micpath.2026.108771_bib95","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/jof11030236","article-title":"The hidden fortress: a comprehensive review of fungal biofilms with emphasis on Cryptococcus neoformans","volume":"11","author":"Pruitt","year":"2025","journal-title":"J. Fungi"},{"issue":"Suppl 1","key":"10.1016\/j.micpath.2026.108771_bib96","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1080\/13693780802238834","article-title":"The characteristics of Aspergillus fumigatus mycetoma development: is this a biofilm?","volume":"47","author":"Mowat","year":"2009","journal-title":"Med. Mycol."},{"issue":"12","key":"10.1016\/j.micpath.2026.108771_bib97","article-title":"Fungal biofilm formation and its regulatory mechanism","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.micpath.2026.108771_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2022.102237","article-title":"Antifungal drug-resistance mechanisms in Candida biofilms","volume":"71","author":"Kaur","year":"2023","journal-title":"Curr. Opin. Microbiol."},{"issue":"11","key":"10.1016\/j.micpath.2026.108771_bib99","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.tim.2009.08.007","article-title":"Can filamentous fungi form biofilms?","volume":"17","author":"Harding","year":"2009","journal-title":"Trends Microbiol."},{"issue":"2","key":"10.1016\/j.micpath.2026.108771_bib100","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/microorganisms14020272","article-title":"Biofilm Formation in Aspergillus fumigatus: a comparative study of strains from different origins","volume":"14","author":"Cano-P\u00e9rez","year":"2026","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.micpath.2026.108771_bib101","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41522-022-00347-3","article-title":"Filamentous fungal biofilms: conserved and unique aspects of extracellular matrix composition, mechanisms of drug resistance and regulatory networks in Aspergillus fumigatus","volume":"8","author":"Liu","year":"2022","journal-title":"npj Biofilms Microbiomes"},{"issue":"8","key":"10.1016\/j.micpath.2026.108771_bib102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009794","article-title":"Aspergillus fumigatus biofilms: toward understanding how growth as a multicellular network increases antifungal resistance and disease progression","volume":"17","author":"Morelli","year":"2021","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.micpath.2026.108771_bib103","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/21501203.2019.1574927","article-title":"Resistance mechanism and proteins in Aspergillus species against antifungal agents","volume":"10","author":"Shishodia","year":"2019","journal-title":"Mycology"},{"issue":"10","key":"10.1016\/j.micpath.2026.108771_bib104","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3390\/jof11100695","article-title":"The Aspergillus fumigatus extracellular polysaccharide galactosaminogalactan displays context-dependent cooperative and competitive social traits in mixed biofilms","volume":"11","author":"Cong","year":"2025","journal-title":"J Fungi (Basel)"},{"issue":"10","key":"10.1016\/j.micpath.2026.108771_bib105","doi-asserted-by":"crossref","first-page":"6350","DOI":"10.1128\/IAI.73.10.6350-6362.2005","article-title":"Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy","volume":"73","author":"Martinez","year":"2005","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.micpath.2026.108771_bib106","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MB-0006-2014","article-title":"Biofilm formation by Cryptococcus neoformans","volume":"3","author":"Martinez","year":"2015","journal-title":"Microbiol. Spectr."},{"issue":"5","key":"10.1016\/j.micpath.2026.108771_bib107","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/mmi.14565","article-title":"Combatting the evolution of antifungal resistance in Cryptococcus neoformans","volume":"114","author":"Bermas","year":"2020","journal-title":"Mol. Microbiol."},{"issue":"3","key":"10.1016\/j.micpath.2026.108771_bib108","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1128\/AAC.50.3.1021-1033.2006","article-title":"Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro","volume":"50","author":"Martinez","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108771_bib109","first-page":"11","article-title":"Biofilm formation by Histoplasma capsulatum in different culture media and oxygen atmospheres","author":"Gon\u00e7alves","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108771_bib110","first-page":"15","article-title":"Paracoccidioides spp.: the structural characterization of extracellular matrix, expression of glucan synthesis and associated genes and adhesins during biofilm formation","author":"Oliveira","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108771_bib111","article-title":"Common virulence factors between Histoplasma and Paracoccidioides: recognition of Hsp60 and Enolase by CR3 and plasmin receptors in host cells","volume":"7","author":"de Matos Silva","year":"2024"},{"issue":"1","key":"10.1016\/j.micpath.2026.108771_bib112","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1186\/s12866-025-04472-9","article-title":"Clinical profiling, antifungal drug susceptibility, and biofilm formation ability in pulmonary mucormycosis","volume":"25","author":"Wang","year":"2025","journal-title":"BMC Microbiol."},{"issue":"7","key":"10.1016\/j.micpath.2026.108771_bib113","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/EC.00060-10","article-title":"Genomic plasticity of the human fungal pathogen Candida albicans","volume":"9","author":"Selmecki","year":"2010","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.micpath.2026.108771_bib114","first-page":"17","article-title":"Fungi between threat and promise: global perspectives on health and innovation","author":"Li","year":"2026","journal-title":"Front. Microbiol."},{"issue":"14","key":"10.1016\/j.micpath.2026.108771_bib115","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.3390\/ijms20143597","article-title":"Transposable elements adaptive role in genome plasticity, pathogenicity and evolution in fungal phytopathogens","volume":"20","author":"Mat Razali","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.micpath.2026.108771_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009935","article-title":"Dynamic genome plasticity during unisexual reproduction in the human fungal pathogen Cryptococcus deneoformans","volume":"17","author":"Fu","year":"2021","journal-title":"PLoS Genet."},{"key":"10.1016\/j.micpath.2026.108771_bib117","first-page":"15","article-title":"Unveiling genome plasticity as a mechanism of non-antifungal-induced antifungal resistance in Cryptococcus neoformans","author":"Zheng","year":"2024","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.micpath.2026.108771_bib118","article-title":"Fungal stress responses and the importance of GPCRs","volume":"11","author":"Lara-Mart\u00ednez","year":"2025","journal-title":"J Fungi (Basel)"},{"issue":"9","key":"10.1016\/j.micpath.2026.108771_bib119","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1080\/09168451.2016.1162085","article-title":"Signaling pathways for stress responses and adaptation in Aspergillus species: stress biology in the post-genomic era","volume":"80","author":"Hagiwara","year":"2016","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"1","key":"10.1016\/j.micpath.2026.108771_bib120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/jof12010008","article-title":"From the ground to the clinic: the evolution and adaptation of fungi","volume":"12","author":"Corr\u00eaa-Junior","year":"2026","journal-title":"J. Fungi"},{"issue":"2","key":"10.1016\/j.micpath.2026.108771_bib121","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3390\/jof11020143","article-title":"Insight into the mechanisms and clinical relevance of antifungal heteroresistance","volume":"11","author":"Su","year":"2025","journal-title":"J Fungi (Basel)"},{"issue":"4","key":"10.1016\/j.micpath.2026.108771_bib122","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3390\/encyclopedia2040118","article-title":"Antifungals and drug resistance","volume":"2","author":"Hossain","year":"2022","journal-title":"Encyclopedia"},{"issue":"3","key":"10.1016\/j.micpath.2026.108771_bib123","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/jof12030229","article-title":"Aspergillosis: an update on epidemiology, risk factors, diagnosis, susceptibility, and treatment","volume":"12","author":"Castro-Fuentes","year":"2026","journal-title":"J. Fungi"},{"issue":"2","key":"10.1016\/j.micpath.2026.108771_bib124","doi-asserted-by":"crossref","first-page":"212","DOI":"10.17843\/rpmesp.2025.422.14195","article-title":"Cryptococcus gattii meningitis in an immunocompromised patient in a hospital in the Peruvian Amazon: case report","volume":"42","author":"Moreno-Soto","year":"2025","journal-title":"Rev. Peru. Med. Exp. Salud Publica"},{"issue":"2","key":"10.1016\/j.micpath.2026.108771_bib125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/jof7020151","article-title":"Endemic and other dimorphic mycoses in the Americas","volume":"7","author":"Lockhart","year":"2021","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"10.1016\/j.micpath.2026.108771_bib126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0013819","article-title":"Paracoccidioidomycosis in the 21st century: challenges and milestones","volume":"20","author":"Venturini","year":"2026","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"5","key":"10.1016\/j.micpath.2026.108771_bib127","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3390\/jof9050533","article-title":"Current progress in Sporothrix brasiliensis basic aspects","volume":"9","author":"G\u00f3mez-Gaviria","year":"2023","journal-title":"J Fungi (Basel)"},{"issue":"2","key":"10.1016\/j.micpath.2026.108771_bib128","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/ejhpharm-2020-002604","article-title":"Antifungal drug resistance: an update","volume":"29","author":"Denning","year":"2022","journal-title":"Eur. J. Hosp. Pharm."},{"key":"10.1016\/j.micpath.2026.108771_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.177923","article-title":"Evaluation of environmental factors related to Aspergillus fumigatus azole resistance in the Netherlands","volume":"958","author":"Cogliati","year":"2025","journal-title":"Sci. Total Environ."},{"issue":"2","key":"10.1016\/j.micpath.2026.108771_bib130","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.3390\/ijms24021584","article-title":"Pathogenic drug resistant fungi: a review of mitigation strategies","volume":"24","author":"Garvey","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.micpath.2026.108771_bib131","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s40588-024-00219-8","article-title":"Emerging antifungal resistance in fungal pathogens","volume":"11","author":"Hui","year":"2024","journal-title":"Curr. Clin. Microbiol. Rep."},{"issue":"5","key":"10.1016\/j.micpath.2026.108771_bib132","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02593-20","article-title":"Antifungal activity of Acylhydrazone derivatives against Sporothrix spp","volume":"65","author":"Artunduaga Bonilla","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.micpath.2026.108771_bib133","doi-asserted-by":"crossref","DOI":"10.1055\/s-0035-1562898","article-title":"New developments in blastomycosis","volume":"36","author":"Smith","year":"2015","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.micpath.2026.108771_bib134","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3390\/jof6040213","article-title":"Novel antifungal agents and their activity against Aspergillus species","volume":"6","author":"Vahedi-Shahandashti","year":"2020","journal-title":"J Fungi (Basel)"},{"issue":"2","key":"10.1016\/j.micpath.2026.108771_bib135","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/21505594.2016.1196300","article-title":"Combinatorial strategies for combating invasive fungal infections","volume":"8","author":"Spitzer","year":"2017","journal-title":"Virulence"},{"issue":"1","key":"10.1016\/j.micpath.2026.108771_bib136","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1128\/AAC.50.1.113-120.2006","article-title":"Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis","volume":"50","author":"Schwarz","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.micpath.2026.108771_bib137","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/AAC.48.3.693-715.2004","article-title":"Combination antifungal therapy","volume":"48","author":"Johnson","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.micpath.2026.108771_bib138","doi-asserted-by":"crossref","first-page":"12","DOI":"10.21767\/2471-8521.100012","article-title":"Combination antifungal therapy for invasive aspergillosis revisited","volume":"2","author":"Panackal","year":"2016","journal-title":"Med Mycol Open Access"},{"issue":"3","key":"10.1016\/j.micpath.2026.108771_bib139","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3390\/ph18030364","article-title":"Beyond conventional antifungals: combating resistance through novel therapeutic pathways","volume":"18","author":"Hetta","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"11","key":"10.1016\/j.micpath.2026.108771_bib140","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae646","article-title":"CAF to the rescue! potential and challenges of combination antifungal therapy for reducing morbidity and mortality in hospitalized patients with serious fungal infections","volume":"11","author":"Jacobs","year":"2024","journal-title":"Open Forum Infect. Dis."},{"issue":"2","key":"10.1016\/j.micpath.2026.108771_bib141","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s40121-022-00606-y","article-title":"Coccidioidomycosis: a contemporary review","volume":"11","author":"Crum","year":"2022","journal-title":"Infect. Dis. Ther."},{"issue":"37","key":"10.1016\/j.micpath.2026.108771_bib142","article-title":"Effective treatment using itraconazole combined with terbinafine in the treatment of nasal sporotrichosis: a case report","volume":"98","author":"Guo","year":"2019","journal-title":"Medicine (Baltim.)"},{"issue":"2","key":"10.1016\/j.micpath.2026.108771_bib143","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/jof10020101","article-title":"A randomized clinical trial comparing itraconazole and a combination therapy with itraconazole and potassium iodide for the treatment of feline sporotrichosis","volume":"10","author":"Reis","year":"2024","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.micpath.2026.108771_bib144","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.2147\/IDR.S466336","article-title":"Strategies of pharmacological repositioning for the treatment of medically relevant mycoses","volume":"17","author":"G\u00f3mez-Gaviria","year":"2024","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.micpath.2026.108771_bib145","first-page":"9","article-title":"Drug repurposing to fight colistin and carbapenem-resistant bacteria","author":"Peyclit","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"13","key":"10.1016\/j.micpath.2026.108771_bib146","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.1007\/s00253-021-11407-7","article-title":"Drug repurposing strategies in the development of potential antifungal agents","volume":"105","author":"Zhang","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2026.108771_bib147","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/msb.2011.31","article-title":"Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole","volume":"7","author":"Spitzer","year":"2011","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.micpath.2026.108771_bib148","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.phrs.2014.03.002","article-title":"The pharmacology of statins","volume":"88","author":"Sirtori","year":"2014","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.micpath.2026.108771_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.04.021","article-title":"Repurposing and optimization of drugs for discovery of novel antifungals","volume":"27","author":"Donlin","year":"2022","journal-title":"Drug Discov. Today"},{"issue":"12","key":"10.1016\/j.micpath.2026.108771_bib150","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3390\/jof9121166","article-title":"Miltefosine: a repurposing drug against mucorales pathogens","volume":"9","author":"Xisto","year":"2023","journal-title":"J Fungi (Basel)"},{"issue":"9","key":"10.1016\/j.micpath.2026.108771_bib151","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00699-21","article-title":"In vitro and in vivo antifungal activity of buparvaquone against Sporothrix brasiliensis","volume":"65","author":"Borba-Santos","year":"2021","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026004973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026004973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T14:20:50Z","timestamp":1788358850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401026004973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":152,"alternative-id":["S0882401026004973"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108771","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antifungals: mechanism of action, resistance, and therapeutic perspectives","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108771","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108771"}}